Содержание
- 2. Infections Toxoplasmosis Rubella Varicella Parvovirus CMV HIV Syphilis
- 3. Introduction 3% of the perinatal mortalities are related to (fetal infection) Fetus can be affected at
- 4. Red indicates the most vulnerable period of development. (Moore 143).
- 5. First Trimester Organogenesis Growth restriction Second and Third Trimester Neuological Impairment Growth restriction
- 6. Think of fetal infection I.U.G.R Hepatic Calcification Intracrainal Calcification Hydrocephally, Microcephally Ascits Pericardial,Pleural Effusion Non Immune
- 13. Toxoplasmosis - Toxoplasmon gondii (intracellular parasite) Trans-placental affect the placenta fetus Transmission Rate - 10 –15%
- 15. Toxoplasmosis Toxoplasmosis - Incidence of congenital toxoplasmosis - 0.07 – 0.5 : 1000 London - 2
- 16. Risks to the Fetus 1st Trimester - 55 – 85% will show sequilie - Chrioretinitis severe
- 17. Toxoplasmonsis Ultra Sound - Intracranial, hepatic, calcification - Ascitis - Hepatosplenomegally - Microcephally - I.U.G.R Diagnosis
- 18. Toxoplasmosis Treatment - Reduce risk of transmission Spiramycin - If fetal infection documented - Pyrimethamine -
- 19. Pyron F, Wallonlion C, Goner P, Cochrane Database Review January 2005 Objective To assess whether treatment
- 20. Look, outcome of the children 3332 Papers identified
- 21. NO Trial fulfill the criteria
- 22. Conclusion We do not know whether antibiotics Treatment reduces the congenital transmission or not. Screening is
- 23. Toxoplasmosis Prevention to Toxoplasmosis: Advice to Pregnant Women whose Serological Tests are Negative. Cook meat at
- 24. Cont.. Prevention of Toxoplasmosis Carefully wash hands after handling raw meat, dirt, or vegetables soiled by
- 32. Rubella German Measles Rubella - 3rd Disease RNA Virus - Respiratory secretions - 2 – 3
- 33. Rubella - 0.5 – 2% Non Immune - 0.2 – 0.5 Congenital Rubella Syndrome Risk of
- 34. Rubella Ultra Sound - I.U.G.R. - Hepto-splenomegally Congenital Rubella syndrome - Eye Cataract, Retinopathy Microphthalmia, glaucoma
- 35. Rubella Diagnosis IgM
- 36. RUBELLA Prevention Active immunization by vaccination is the only efficient way of preventing congenital rubella.
- 39. Varicella Zoster Virus DNA Herpes - Chickenpox - Herpes Zoster - Incidence in pregnancy 0.4 –
- 40. Varicella Neonatal Infection Increase in Mortality - 5 days before delivery – 48 hours post partum
- 41. Diagnosis Viral Culture - PCR Presence of infection does not predicate the severity of the disease
- 42. VARICELLA Prevention Passive immunization is currently available and should be administered within 24-72 hours to sero-negative
- 43. Varicella Treatment - Oral cyclovir to improve sysmatic I.V. to treat pneumonia - Safe in Pregnancy
- 44. Varicella Screening - Not Recommended
- 47. Parvovirus B.19 the fifth disease Infectious period 5 – 10 days after exposure Mode of transmission
- 48. Intrauterine fetal infection Fetal effect of B19 : - A symptomatic - IUGR - Congenital anomalies
- 49. Diagnosis Parpovirus - ELISA -Western blot test IGM Diagnosis of Primary Infection Elect Microscopy - Direct
- 50. Parvovirus Fetal Diagnosis PCR in A.F., Placenta & Blood Ultra Sound Hydropy Fetalis
- 51. Parvovirus Prognosis and therapy Survivor recovers normal Fetal Therapy Intravascualr Intrauterine Blood Transfusion
- 55. CMV DNA Herpes Virus Most common perinatal infection 0.2 – 2% of all newborns Leading cause
- 56. CMV I.P 28 – 60 days Viremia 2 – 3 weeks Maternal effect – Asympathic, mild
- 57. Epidimulogical Facts Primary Infection -Risk of Transmission 30 – 40% -10% Seguilie of the infected -30%
- 58. Recurrent Infection Transmission 0.1 – 2% Mostly a symptomatic most of the sequilie occurs as hearing
- 59. Diagnosis CMV Diagnosis Culture or PCR – blood, urine & salvia IgG Serial Measurements 3 –
- 60. IGM is not reliable as it may be negative even in the right phase and may
- 61. Diagnosis Fetal Diagnosis Ultra Sound System - Intracrainal or hepatic calcification - Echogenic bowel - Ascits
- 62. CMV Treatment - Not available - Neonatal therapy ganciclovir may decrease neonatal infections Vaccine - May
- 67. Human immunodeficiency virus (HIV) Infection This is the major cause of congenital infection in the developing
- 68. Mother ? child in utero at birth breast milk Organ/tissue donation Semen Kidneys Skin, bone marrow,
- 69. TO SCREEN OR NOT TO SCREEN? The best defense is a strong offense. The American Academy
- 70. PRE-TEST COUNSELING Risks of transmission (including Mode) Risks of perinatal transmission Potential social and psychological implication
- 71. Timing of Perinatal HIV Transmission Cases documented intrauterine, intrapartum, and postpartum by breastfeeding In utero -
- 72. Factors Influencing Perinatal Transmission Maternal Factors HIV-1 RNA levels (viral load) Low CD4 lymphocyte count Other
- 73. Reducing HIV Transmission with Suboptimal Regimens Partial ZDV regimens: ( New York cohort) Transmission rates 6.1%
- 74. Reducing Intrapartum HIV Transmission: Studies of Short Course Therapy Oral ZDV in a non-breastfeeding population (Thailand)
- 75. Treatment with zidovudine appears to be safe in pregnancy. Elective caesarean section may decrease mother-to-child transmission.
- 76. HIV Chochrane Database 2002 Objective to assess what intervention will decrease the risk of mother to
- 77. AZT 4 trials decrease 1585 patients Neviropine compared AZT 626 decrease transmission C/S one trial 436
- 78. Conclusion Zidoridine, Nevirpine C/S decreases the transmission significantly.
- 79. Syphilis - T.P. - Increase HIV Transmission all through
- 80. Manifestation Ultra Sound Thick Placenta Hydrops fetalis I.U.G.R Hydroamnios – Hepato-splenomegaly …… Risk of Transmission 90%
- 81. Diagnosis Screening Non Specific VDAL RPR Specific TPHA F.T.A. becomes ….. 3 – 4 weeks
- 82. Treatment - Penicillin - Benzathin Penicillin 2.4 million unit - Erythpromycine
- 90. Скачать презентацию